Details for 2023175752

Up to date per 03.04.2026

Actions

Title / Product Name

ZUSAMMENSETZUNG ENTHALTEND EINEN 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR UND EINEN AKT INHIBITOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023175752

EP Publication Number

4265300

E-Number

1865492

Language

PCT Number

Publication Date

25.10.2023 A

10.12.2025 B1

Registration Date

10.12.2025

AT Publication Date

15.12.2025

Application Date

01.10.2014

Registration Number

Priorities

01.10.2013

201361885049 P

30.01.2014

201461933379 P

IPC

A61K 31/4155 20060101AFI20231025BHEP

Maximum Duration of Protection

01.10.2034

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CORNFELD, Mark J. Collegeville, 19426US

KUMAR, Rakesh Collegeville, 19426US

MORRIS, Shannon Renae Research Triangle, 27709US

Information about Fees